216 related articles for article (PubMed ID: 29209141)
21. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
[TBL] [Abstract][Full Text] [Related]
22. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma.
Deng W; Xie Z; Chen L; Li W; Li M
Aging (Albany NY); 2024 Jan; 16(2):1249-1275. PubMed ID: 38271056
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma.
Liu S
Eur J Med Res; 2024 Jan; 29(1):70. PubMed ID: 38245763
[TBL] [Abstract][Full Text] [Related]
24. An improved clear cell renal cell carcinoma stage prediction model based on gene sets.
Li F; Yang M; Li Y; Zhang M; Wang W; Yuan D; Tang D
BMC Bioinformatics; 2020 Jun; 21(1):232. PubMed ID: 32513106
[TBL] [Abstract][Full Text] [Related]
25. Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma.
Cheng X; Hou Y
Front Oncol; 2023; 13():1280618. PubMed ID: 37927470
[TBL] [Abstract][Full Text] [Related]
26. A novel method to identify pathways associated with renal cell carcinoma based on a gene co-expression network.
Ruan X; Li H; Liu B; Chen J; Zhang S; Sun Z; Liu S; Sun F; Liu Q
Oncol Rep; 2015 Aug; 34(2):567-76. PubMed ID: 26058425
[TBL] [Abstract][Full Text] [Related]
27. Identification of crucial genes through WGCNA in the progression of gastric cancer.
Liu R; Liu J; Cao Q; Chu Y; Chi H; Zhang J; Fu J; Zhang T; Fan L; Liang C; Luo X; Yang X; Li B
J Cancer; 2024; 15(11):3284-3296. PubMed ID: 38817876
[No Abstract] [Full Text] [Related]
28. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression.
Hu J; Wang SG; Hou Y; Chen Z; Liu L; Li R; Li N; Zhou L; Yang Y; Wang L; Wang L; Yang X; Lei Y; Deng C; Li Y; Deng Z; Ding Y; Kuang Y; Yao Z; Xun Y; Li F; Li H; Hu J; Liu Z; Wang T; Hao Y; Jiao X; Guan W; Tao Z; Ren S; Chen K
Nat Genet; 2024 Mar; 56(3):442-457. PubMed ID: 38361033
[TBL] [Abstract][Full Text] [Related]
29. Treg-Related Genes Representing a Potential Shared Biological Mechanism Between Clear Cell Renal Carcinoma and Obesity.
Zhou X; Li P; Xu Q; Ye J
J Coll Physicians Surg Pak; 2024 Feb; 34(2):193-201. PubMed ID: 38342871
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of m
Li H; Li C; Zhang Y; Jiang W; Zhang F; Tang X; Sun G; Xu S; Dong X; Shou J; Yang Y; Chen M
Mol Carcinog; 2024 Apr; 63(4):677-687. PubMed ID: 38362848
[TBL] [Abstract][Full Text] [Related]
31. SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.
Gao Q; Ye X; Li F
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290445
[TBL] [Abstract][Full Text] [Related]
32. ProNetView-ccRCC: A Web-Based Portal to Interactively Explore Clear Cell Renal Cell Carcinoma Proteogenomics Networks.
Kalayci S; Petralia F; Wang P; Gümüş ZH
Proteomics; 2020 Nov; 20(21-22):e2000043. PubMed ID: 32358997
[TBL] [Abstract][Full Text] [Related]
33. Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.
Li HJ; Li WX; Dai SX; Guo YC; Zheng JJ; Liu JQ; Wang Q; Chen BW; Li GH; Huang JF
Oncol Lett; 2018 Feb; 15(2):2316-2322. PubMed ID: 29434939
[TBL] [Abstract][Full Text] [Related]
34. Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
Wu D; Xu Z; Shi Z; Li P; Lv H; Huang J; Fu D
Comput Math Methods Med; 2022; 2022():4456987. PubMed ID: 36081434
[TBL] [Abstract][Full Text] [Related]
35. Re: Multi-omic Profiling of Clear Cell Renal Cell Carcinoma Identifies Metabolic Reprogramming Associated with Disease Progression.
Jiang A; Qu L; Cai C; Luo P; Wang L
Eur Urol; 2024 Jul; 86(1):76-77. PubMed ID: 38614822
[No Abstract] [Full Text] [Related]
36. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
[TBL] [Abstract][Full Text] [Related]
37. Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma.
Zamora-Fuentes JM; Hernández-Lemus E; Espinal-Enríquez J
Front Genet; 2020; 11():578679. PubMed ID: 33240325
[TBL] [Abstract][Full Text] [Related]
38. Co-expression Network Analysis Reveals Key Genes Related to Ankylosing spondylitis Arthritis Disease: Computational and Experimental Validation.
Najafzadeh L; Mahmoudi M; Ebadi M; Dehghan Shasaltaneh M
Iran J Biotechnol; 2021 Jan; 19(1):e2630. PubMed ID: 34179194
[TBL] [Abstract][Full Text] [Related]
39. Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma.
Aydin B; Arga KY
Front Endocrinol (Lausanne); 2019; 10():361. PubMed ID: 31244774
[TBL] [Abstract][Full Text] [Related]
40. Skipping of
Feldner AC; Turner AK; Simpson JF; Estus S
J Alzheimers Dis Rep; 2023; 7(1):1313-1322. PubMed ID: 38143775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
